Quantum redactiones paginae "Sclerosis lateralis amyotrophica" differant

'''Sclerosis lateralis amyotrophica''' <ref>[http://www.researchgate.net/publication/34151928_ber_Sclerosis_lateralis_amyotrophica__inaugural-Dissertation_welche_zur_Erlangung_der_Doctorwrde_in_der_Medicin_und_Chirurgie_mit_Zustimmung_der_medicinischen_Facultt_der_Friedrich-Wilhelms-Universitt_zu_Berlin_am_23._Juli_1895_nebst_den_angefgten_Thesen_ffentlich_vertheidigen_Wird_ Dissertatio,] www.researchgate.net.</ref> ([[ICD-10]]: G12.2) est gravis [[neurodegeneratio|morbus]] [[systema nervosum|systematis nervosi]], accurate [[Neuron|neuronum]] [[motus|motoriorum]] demutatio. Hic morbus, qui [[morbus degenerativus|degenerat]] dum progenitur, adhuc hodie [[sanatio|sanari]] non potest, et ad extremum in [[mors|mortem]] ducit. Primum hunc morbum descripsit [[medicus]] [[Francia|Francicus]] [[Ioannes Martinus Charcot]].

In [[Italia]] multi [[pedilusor]]es hoc morbo mortui sunt, ergo putatur scilicet etiam [[venenum|venena]] contra mala [[gramen|gramina]], quae in pediludii campis utuntur, sclerosem lateralem amyotrophicam generare possunt.<ref>M. Vinceti, I. Bottecchi, A. Fan, Y. Finkelstein, J. Mandrioli (2012): Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? In: Rev Environ Health, vol. 1, pp. 19-41</ref> Non est remedia plena at ad morbum allevandi, [[technologia adiuvans]] vel [[communicatio augmentans et alternativa]] utetur.

Neuronibus motoriorum degeneratis et superioribus et inferioribus symptomata[[symptoma]]ta ac signa [[musculus|musculorum]] et tenuitas (atrophia) et infirmitas corporis apparent. Cum initium non rare obscure esset, in morbi cursu symptomata muscularia progrediantur. Adhuc omnibus rationibus infrenata, postremo morbus quamcumque gubernationem motuum voluntariam affert, quamquam et [[vesica urinaria|vesicae]] et tractūs gastrointestinalis et [[musculus externus bulbi oculi|musculorum bulbi oculi externorum]] gubernatio saepe usque ad extremum intacta restabit<ref>{{cite journal |authors=Hobson EV, McDermott CJ |title=Supportive and symptomatic management of amyotrophic lateral sclerosis |journal=Nat Rev Neurol |year=2016 |volume=12 |pages=526-38 |url=https://www.ncbi.nlm.nih.gov/pubmed/27514291}}</ref>.